The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study (Q42828977)

8 November 2017

The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: a pilot study (English)

1 reference

8 November 2017

0 references

1 reference

Eun Jung Bak

1

1 reference

8 November 2017

Hong Gyu Park

2

1 reference

8 November 2017

Minyoung Kim

3

1 reference

8 November 2017

Sung Whan Kim

4

1 reference

8 November 2017

Sungwuk Kim

5

1 reference

8 November 2017

Seong-Ho Choi

6

1 reference

8 November 2017

Jeong-Heon Cha

7

1 reference

8 November 2017

Yun-Jung Yoo

8

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Journal of Periodontology

8 November 2017

1 reference

8 November 2017

81

1 reference

8 November 2017

3

1 reference

8 November 2017

412-419

1 reference

Osteoclast-osteoblast communication

8 November 2017

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Therapeutic approaches to bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

The interface between obesity and periodontitis with emphasis on oxidative stress and inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

The relationship between oral health and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Diabetes mellitus and inflammatory periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Update on diabetes mellitus: prevention, treatment, and association with oral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Metformin therapy and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Metformin for obesity in children and adolescents: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Bone effects of glitazones and other anti-diabetic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Effect of aminoguanidine in ligature-induced periodontitis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Sublines of mouse 3T3 cells that accumulate lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Topical administration of simvastatin recovers alveolar bone loss in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Obesity, inflammation, and periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2009.090414

21 January 2018

Identifiers

DOI

10.1902/JOP.2009.090414

1 reference

8 November 2017

1 reference